Podcasts about cdces

Most of us assume that if we look healthy on the outside, our heart is fine on the inside, but today, preventive cardiology dietitian Michelle Routhenstein explains why that's exactly the assumption that gets women into trouble, especially through perimenopause and beyond. We get into the two numbers your doctor probably isn't checking, ApoB and Lp(a), the first five diet changes Michelle makes with clients to bring down high cholesterol numbers, why stretching may be doing as much for your arteries as it does for your joints, and why blood pressure, not HRV, deserves far more of your attention as you move through this life stage. WHAT YOU'LL LEARN ●      Why heart disease can silently progress in women who look and feel healthy ●      What ApoB and Lp(a) actually measure, and why they matter more than LDL and HDL alone ●      The first five diet changes to lower high ApoB or non HDL cholesterol ●      Why saturated fat, fiber, and gut health all influence your cholesterol numbers ●      Why blood pressure, not HRV, deserves more of your attention in perimenopause ●      How menopause hormone therapy really affects your cardiovascular risk ●      The minerals your heart needs to keep beating and pumping properly TIMESTAMPS 00:00 Heart Disease Risk in Women: ApoB, Lp(a), and the Tests Your Doctor Isn't Running 10:18 The Hidden Inflammation Driving Your Heart Disease Risk (And How to Test for It) 19:29 The Truth About Saturated Fat and Cholesterol After 40 22:19 The First Five Diet Changes to Lower High ApoB or Non HDL Cholesterol 29:24 Bloating, Gut Health and Thyroid: The Hidden Heart Disease Risks in Perimenopause 39:41 Why Stretching Might Be Protecting Your Arteries, Not Just Your Joints 51:48 Does Menopause Hormone Therapy Actually Protect Your Heart? VALUABLE RESOURCES • Take the BioSyncing Quiz to help you understand what's actually happening in your body — and how to fix it.

Loneliness and Social Isolation: What is Our Roles as CDCESs?, Megan Muñoz, RN, MSN, CDCES, ADCES In Practice, 2026 Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcastLearn more about ADCES and the many benefits of membership at adces.org/join.The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most of us have had that moment where we get our bloodwork back and shake our heads. We're still our active, health‑minded selves and out of nowhere—rising LDL, ApoB, A1C, and maybe blood pressure and Lp(a), too. This week, preventive cardiology dietitian Michelle Routhenstein joins us to unpack the cardiometabolic chaos and what's really driving it. She explains estrogen's protective role in lipids and blood pressure, why standard risk calculators and even calcium scores can miss women's disease, and which advanced labs are worth asking for. We also dig into how under‑fueling and low‑carb diets can worsen cardiometabolic health and plaque; why complex carbs, fiber, fermented foods, and gut health matter so much; and how to approach protein, red meat, electrolytes, nitric oxide, and statins in a personalized, empowering way—remembering that 80–90% of heart disease remains preventable when women get the right information and advocate for themselves.Michelle Routhenstein, MS, RD, CDCES, CDN is a preventive cardiology dietitian and founder of Entirely Nourished, a virtual practice focused on personalized, science-based nutrition for heart health. With over 14 years of experience, she helps people improve cardiometabolic risk and manage conditions like atherosclerosis, heart failure, and atrial fibrillation using a whole-person approach. She holds Bachelor's and Master's degrees in Clinical Nutrition from New York University, serves on the Forbes Health Advisory Board and the Medical Advisory Committee for the National Menopause Foundation, and is the author of The Truly Easy Heart-Healthy Cookbook and Simple Meal Solutions for High Blood Pressure. Her work has been featured in outlets including Forbes Health, Fox News, Prevention, Women's Health, and Good Housekeeping, and she works with clients virtually from New York via www.entirelynourished.comJoin us at Feisty Fest September 18-20, 2026: https://feisty.co/events/feisty-fest/Sign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/Learn More about our 2026 Feisty Events, including Bike Camps and Cycling Trips: https://feisty.co/events/Follow Us on Instagram:Feisty Menopause: @feistymenopauseHit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Previnex: Get 20% off your order with code FEISTYBRAIN at https://www.previnex.com/ Wahoo: Use the code FEISTY2026 to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/WVhdrCozy Earth: Use Code HITPLAY at https://cozyearth.com/ for up to 20% off

Struggling to manage blood sugar or navigate diabetes effectively? In this episode, Kathy Levin, RDN, CDCES, and DipACLM, shares practical, sustainable strategies for controlling diabetes, improving metabolic health, and creating long-term wellness. A board-certified lifestyle medicine dietitian and certified diabetes educator, Kathy has helped countless individuals take control of their health through simple nutrition and lifestyle changes. Her signature THRIVE framework emphasizes gradual, realistic habits that produce lasting results. In this conversation, we explore: ·       Key factors that drive inflammation and contribute to chronic disease. ·       How Kathy's personal and professional experience with diabetes shaped her approach. ·       Why conventional healthcare approaches can fall short in diabetes management. ·       Trends in pediatric diabetes and strategies to prevent and manage it. ·       Practical steps to improve blood sugar control, reduce medication reliance, and adopt sustainable habits. Whether you're managing type 2 diabetes, prediabetes, or supporting a loved one, this episode offers actionable guidance to regain control of your health and thrive. Learn more about Kathy Levin and her work with Nutritiously Simple here. Episode also available on Apple Podcasts: https://apple.co/38oMlMr  Keep up with Kathy Levin socials here: Instagram: https://www.instagram.com/thelifestylemedicinedietitian/ 

Guest: Denee BexShow Notes:Indigenous foodways aren't trends, they're heart-healthy blueprints. This episode maps how traditional ingredients, cooking methods, and land stewardship support cardiovascular health today, with practical ideas for reconnecting even when access is limited.Guest Bio:Denee Bex is a Registered Dietitian & CDCES from the Diné (Navajo) Nation and is the owner of Tumbleweed Nutrition LLC, a dietetics and nutrition education consulting firm. She teaches her Native community about nutrition without judgement. Denee provides inclusive & evidence-based nutrition education for organizations which honor American Indian heritage.Quote:“Food is more than sustenance. Food is also community. Food is also family. Food is also connection. And that's something that many of our Indigenous families, Native families have known for centuries, if not thousands of years.”Question of the Day:Which traditional or ancestral food from your own culture would you like to explore or incorporate more often for better heart health?On This Episode You Will Learn:Why culturally relevant nutrition care is essential for Indigenous communities.How traditional Indigenous foods can support heart health and blood sugar.How food plays a role in culture, identity, and connection, not just nutrition.Why Indigenous foods are often missing from mainstream nutrition research.How individuals and healthcare providers can better support Indigenous food systems.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Denee Bex!Website URL: www.tumbleweednutrition.comInstagram URL: @tumbleweed_nutritionFacebook URL: Tumbleweed Nutrition

GLP-1 receptor agonists are reshaping diabetes and obesity care, raising important questions about patient selection, side effect management, long-term outcomes, access, and the evolving role of diabetes care and education specialists (DCESs). In this episode of Diabetes Care Conversations, host Paola Acevedo, PharmD, CDCES, speaks with Diana Isaacs, PharmD, BC-ADM, CDCES, about what DCESs need to know about GLP-1 therapies, including their impact on treatment approaches, the importance of patient education, and emerging opportunities and challenges in care. Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Heart disease is the leading cause of death in women, yet awareness is still surprisingly low. In this episode of The Positive Pause®, host Claire Gill sits down with two of NMF's Medical Advisory Committee (MAC) members, Dr. Emily Lau, a cardiologist specializing in women's cardiovascular health, and Michelle Routhenstein, a preventive cardiology dietitian, to unpack why midlife is a critical window for prevention and what women can do to take control of their heart health.They explore how menopause changes cardiovascular risk, why heart disease often goes unnoticed, and how small, sustainable lifestyle changes can have a major impact.Emily Lau, MD, MPH a women's cardiovascular health specialist and investigator at Mass General Brigham. Dr. Lau co-directs the Women's Heart Health Program. Dr. Lau's laboratory focuses on understanding how biologic sex differences and female-specific cardiovascular risk factors contribute to the pathogenesis of cardiovascular disease uniquely in women. Michelle Routhenstein, MS, RD, CDCES, CDN, is the owner and president of Entirely Nourished LLC, a specialized private practice in nutrition counseling and consulting focused on the prevention and management of heart disease. Employing a science-based, holistic approach, she is dedicated to enhancing women's heart health by addressing cardiometabolic risk factors and mitigating the likelihood of cardiovascular issues as individuals age.Key Concepts CoveredMidlife is a turning point for heart healthCardiovascular risk accelerates during and after menopause, making this stage of life a critical opportunity for prevention.Heart disease is often silent and under-recognizedMany women don't realize there's an issue because symptoms aren't obvious. At the same time, awareness has actually declined in recent years, which makes education even more important.Health goes beyond weight and appearanceYou can look healthy and still have underlying cardiovascular risk. That's why personalized testing and understanding your numbers matters.Sustainable habits matter more than extreme changesInstead of restrictive diets or drastic routines, small consistent improvements in nutrition, movement, sleep, and stress management lead to better long-term outcomes.Prevention is the real opportunityMidlife isn't just a time of change; it's a chance to take control. With the right approach, most cardiovascular risk factors can be improved or prevented.This conversation makes one thing clear: heart health isn't something women can afford to ignore, especially at midlife. The good news is that most risk factors are preventable and manageable with the right information and consistent action. By focusing on sustainable habits and understanding your personal risk, you can take control of your cardiovascular health and build a stronger future.Connect with Dr. Lau:Website: Mass General Brigham Women's Heart HealthLinkedIn: https://www.linkedin.com/in/emily-lau-11601152/ Instagram: https://www.instagram.com/‌massgeneral Connect with Michelle:Website: https://www.entirelynourished.comLinkedIn: https://linkedin.com/in/michellerouthenstein/Instagram: https://www.instagram.com/heart.Health.Nutritionist/

Acute rescue medications are critical in time-sensitive emergencies, and pharmacists play an essential role in ensuring patients and caregivers are prepared to use them correctly. This course discusses the roles of glucagon, naloxone, and epinephrine, including recent updates on novel formulations and device innovations that are reshaping emergency response in community settings. You will gain practical insights to strengthen counseling, improve readiness, and support optimal outcomes when seconds matter most. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTWendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPTProfessor of Pharmacy PracticeDrake University CPHS Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the mechanisms of action and primary indications for glucagon, naloxone, and epinephrine as acute rescue medications.2. Summarize recent updates for glucagon, naloxone, and epinephrine that impact pharmacist counseling and patient access.Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Wendy Mobley-Bukstein is a Diabetes Care Speaker for Abbott. All relevant financial relationships have been mitigated.  0.05 CEU/0.5 HrUAN: 0107-0000-26-131-H01-P Initial release date: 5/18/2026Expiration date: 5/18/2027Additional CPE details can be found here.

Acute rescue medications are critical in time-sensitive emergencies, and pharmacists play an essential role in ensuring patients and caregivers are prepared to use them correctly. This course discusses the roles of glucagon, naloxone, and epinephrine, including recent updates on novel formulations and device innovations that are reshaping emergency response in community settings. You will gain practical insights to strengthen counseling, improve readiness, and support optimal outcomes when seconds matter most.HOSTRachel Maynard, PharmD GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTWendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPTProfessor of Pharmacy PracticeDrake University CPHSGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the mechanisms of action and primary indications for glucagon, naloxone, and epinephrine as acute rescue medications.2. Summarize recent updates for glucagon, naloxone, and epinephrine that impact pharmacist counseling and patient access.Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Wendy Mobley-Bukstein is a Diabetes Care Speaker for Abbott. All relevant financial relationships have been mitigated.  0.05 CEU/0.5 HrUAN: 0107-0000-26-131-H01-P Initial release date: 5/18/2026Expiration date: 5/18/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, join Over the Counter to discuss the modern push toward diabetes care and why the pharmacist's role has never been more important.

GLP-1 medications are everywhere right now, but the conversation around them often lacks nuance and is rarely discussed through the lens of active people. That's exactly why I'm doing a 3-part podcast series all about GLP-1 medications, with athletes in mind.In this series, you'll hear from three dietitians who regularly work with GLP-1 agonists and each bring a unique clinical and personal perspective to the conversation.I'm kicking things off in episode 135 with Courtney Smith, MS, RD, CDCES, a sports dietitian, diabetes specialist, and longtime endurance athlete.Together, we break down the basics of GLP-1 medications and what active people need to know in the context of training and health.Courtney and I discuss:The history of GLP-1 medications, especially in diabetic populationsWhy they have exploded in popularity in recent yearsHow the various drugs on the market differ, plus dosing practicesThe benefits and side effects she's observed in practiceHow crucial it is to get ongoing professional support when on GLP-1's, and why you still need to work on diet & lifestyle changesWhy she generally does not recommend GLP-1 drugs for most athletesIf you've been hearing about GLP-1 medications and wondering how they may affect your training, fueling, recovery, blood sugar, or overall health as an active person, this episode will answer your questions while laying an important foundation for the rest of the series to come.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PMA865. CME/CPE/IPCE credit will be available until April 8, 2027.Partners in Shingles Prevention: Turning Patient Insights Into Collaborative Immunization Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PMA865. CME/CPE/IPCE credit will be available until April 8, 2027.Partners in Shingles Prevention: Turning Patient Insights Into Collaborative Immunization Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PMA865. CME/CPE/IPCE credit will be available until April 8, 2027.Partners in Shingles Prevention: Turning Patient Insights Into Collaborative Immunization Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PMA865. CME/CPE/IPCE credit will be available until April 8, 2027.Partners in Shingles Prevention: Turning Patient Insights Into Collaborative Immunization Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PMA865. CME/CPE/IPCE credit will be available until April 8, 2027.Partners in Shingles Prevention: Turning Patient Insights Into Collaborative Immunization Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at PeerView.com/PMA865. CME/CPE/IPCE credit will be available until April 8, 2027.Partners in Shingles Prevention: Turning Patient Insights Into Collaborative Immunization Strategies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

Discover critical digestive health red flags in this informative podcast episode. Liz Deck, FNP-BC, provides detailed explanations about symptoms like bloating, constipation, and heartburn that shouldn't be overlooked. Make sure you're in tune with your body's signals!  Learn more about Liz Deck, FNP-BC, BC-ADM, CDCES, DNP 

This episode of Diabetes Care Conversations explores the professional journeys of two certified diabetes care and education specialists (CDCES), Mayra Cantazaro, DNP, FNP-BC, BC-ADM, CDCES, and Liseli Mulala, RPh, MPH, PhD, CDCES, BCMTMS. The conversation illuminates how careers in diabetes care are often shaped by deeply personal experiences, mentorship, and unexpected opportunities rather than a straight path. Mayra and Liseli discuss the rewards of the profession—from meaningful patient connections and culturally responsive care to interdisciplinary collaboration and community impact. The guests explore how the field has evolved, particularly with advancements in technology, a shift toward patient-centered care, and growing opportunities for leadership and innovation. Listeners will come away inspired to embrace uncertainty, seek mentorship, and embrace the diabetes care journey. Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions.Recent ACC/AHA Cholesterol Guidelines further emphasize comprehensive cardiovascular risk assessment and evidence-based management of dyslipidemia alongside other major risk factors such as hypertension. These updates complement the hypertension topics discussed in this episode by reinforcing the importance of coordinated, risk-based approaches to reducing cardiovascular disease. This resource provides a concise, guideline-based overview of hypertension management, summarizing the 2025 ACC/AHA recommendations for blood pressure classification, treatment goals, and stepwise pharmacotherapy. It highlights first- and second-line antihypertensive options, emphasizes individualized, risk-based treatment decisions, and outlines practical considerations for therapy initiation, intensification, and monitoring to optimize cardiovascular outcomes.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTTomasz Jurga,  PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACCClinical Pharmacist PractitionerLTC Charles S. Kettles VA Medical CenterPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify recent guideline and practice updates that may influence the diagnosis, treatment, and monitoring of hypertension.2. Discuss current and emerging tools and strategies that support safe, effective, and individualized hypertension management.Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Tomasz Jurga has disclosed that a grant from Merck supported Pharmacy Times Continuing Education activities, including speaking honoraria. All relevant financial relationships have been mitigated.0.1 CEU/1.0 HrUAN: 0107-0000-26-073-H01-PInitial release date: 4/6/2026Expiration date: 4/6/2027Additional CPE details can be found here.

Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-pill combination therapy and the clinical limitations of some blood pressure devices, alongside updates to the 2025 hypertension guidelines. You will gain a clear understanding of how these changes affect patient care, medication strategies, and pharmacist-driven interventions.Recent ACC/AHA Cholesterol Guidelines further emphasize comprehensive cardiovascular risk assessment and evidence-based management of dyslipidemia alongside other major risk factors such as hypertension. These updates complement the hypertension topics discussed in this episode by reinforcing the importance of coordinated, risk-based approaches to reducing cardiovascular disease.This resource provides a concise, guideline-based overview of hypertension management, summarizing the 2025 ACC/AHA recommendations for blood pressure classification, treatment goals, and stepwise pharmacotherapy. It highlights first- and second-line antihypertensive options, emphasizes individualized, risk-based treatment decisions, and outlines practical considerations for therapy initiation, intensification, and monitoring to optimize cardiovascular outcomes.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTTomasz Jurga,  PharmD, BCPS, BCACP, BCCP, HF-Cert, CDCES, AACCClinical Pharmacist PractitionerLTC Charles S. Kettles VA Medical CenterGET CE FOR THIS LISTENING!The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that's less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll. PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify recent guideline and practice updates that may influence the diagnosis, treatment, and monitoring of hypertension.2. Discuss current and emerging tools Follow CEimpact on Social Media:LinkedInInstagram

Listen in as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You'll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don't respond to GLP-1 agonists.Special guests:Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, BCACP, CDCES, BC-ADMClinical Professor and Director of Pharmacy EducationUniversity of South Carolina College of PharmacyJennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADMProfessor and the Associate Dean for EducationUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesPanelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure Dr. Jennifer Clements reports relevant financial relationships with Novo Nordisk (Ozempic, Rybelsus), Eli Lilly (Zepbound, tirzepatide) [speakers bureau].The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2026. 

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  transcript with links:  Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Who's in Vegas? I'll see you there at the Breakthrough T1D summit this weekend. And we have two Club 1921 events for health care providers and patient leaders happening in April – head on over to the website for more. Okay.. our top story this week: XX Metformin may be linked to the slower progression of age-related macular degeneration (AMD). Among people with diabetes who were older than 55, those taking metformin had a 37% lower chance of developing intermediate AMD over a five-year period compared with individuals who were not using the medication. It's one of the leading causes of vision loss in the US and many other western countries. These researchers now say a clinical trial is the next step. https://scitechdaily.com/scientists-discover-surprising-eye-benefit-of-widely-used-diabetes-drug/ XX new study suggests people with type 1 diabetes may be nearly three times as likely to develop dementia compared with people without diabetes. Similarly, people with type 2 diabetes may have roughly twice the risk of dementia compared with those without diabetes. However, the study found an association rather than proof of causation, meaning diabetes was linked to dementia risk but was not shown to directly cause it.   https://www.usnews.com/news/health-news/articles/2026-03-19/both-types-of-diabetes-increase-dementia-risk XX Researchers in Japan say they've developed an insulin pill… in mice.  The study, published in the journal Molecular Pharmaceutics, tested the delivery of oral insulin by building a carrier peptide called DNP-V. This peptide helps to transport insulin through the small intestine, where protein drug absorption is usually poor. The result was a rapid and significant drop in blood glucose, as well as a sustained (longer-term) decrease. The mice's blood sugar was reduced to near-normal levels. Although the researchers are optimistic about the findings translating to larger therapeutic models, they noted that the results in mice do not guarantee the same outcome in humans, and that more research is needed. https://www.foxnews.com/health/needle-free-diabetes-management-could-horizon-study-suggests   XX   Lilly says it's next-generation obesity drug retatutride cleared its first late-stage trial on Type 2 diabetes patients. The drug lowered hemoglobin A1C by an average of 1.7% to 2% across different doses at 40 weeks compared with placebo, and helped patients lose an average of 16.8% of their weight. Retatrutide also met the study's second goal, helping patients at the highest dose lose an average of 16.8% of their weight, or 36.6 pounds, at 40 weeks, when evaluating only patients who stayed on the drug. When analyzing all participants, including those who discontinued treatment, the highest dose of the drug helped patients lose 15.3% of their weight. The company was also "very pleased" with the relatively low discontinuation rates due to side effects, which were up to 5%, he added. But Lilly has yet to file for approval of the drug for obesity or diabetes. The company expects to report findings from seven additional phase three trials on the drug by the end of the year. Still, retatrutide's A1C reduction doesn't appear to be the greatest Lilly has seen within its portfolio: The highest dose of Zepbound lowered the measure by more than 2% at 40 weeks in two separate trials on diabetes patients. Dubbed the "triple G" drug, retatrutide works by mimicking three hunger-regulating hormones – GLP-1, GIP and glucagon – rather than just one or two like existing treatments. That appears to have more potent effects on a person's appetite and satisfaction with food than other treatments.   https://www.cnbc.com/2026/03/19/eli-lillys-obesity-drug-retatrutide-clears-late-stage-diabetes-trial.html XX   The MiniMed Flex gets FDA approval. Thi is a new design from the company formerly known as Medtronic. It's about half the size* of the MiniMed™ 780G pump, no screen – smartphone controlled – and has the SmartGuard™ algorithm with Meal Detection™ technolog. At commercial launch, MiniMed Flex™ will support the company's newest sensor portfolio, including Simplera Sync™ sensor and the Instinct sensor, made by Abbott. MiniMed also announced the MiniMed™ Forward Program, which allows customers who start on the MiniMed™ 780G system to upgrade to the MiniMed Flex™ system for $0. MiniMed Flex™ is cleared for individuals ages 7 and older with type 1 diabetes, and for individuals 18 years and older with insulin-requiring type 2 diabetes. https://www.prnewswire.com/news-releases/minimed-announces-fda-clearance-of-minimed-flex-the-companys-smallest-insulin-pump-featuring-its-first-smartphone-controlled-design-302716864.html   XX Lots of new out of the recent ATTD conference.. some headlines: New study from the UK shows that Ketone Monitoring Could Significantly Reduce DKA Risks in people with type 1 and type 2. This was a study by Abbott which recently submitted a continuous dual glucose-ketone monitor to the FDA for clearance – if approved, it could be available in the U.S. later this year. -- The first modified insulin producing cells are still working 14 months after transplant – without the need for immunosuppressive drugs. This is from Sana which now plans a study of a new therapy.. same gene-editing strategy with lab-grown, stem-cell-derived insulin-producing cells. -- Protein looks like it helps avoid lows during exercise. Both high and low doses of whey protein before exercise were effective, significantly reducing the risk of hypoglycemia by five to 10 times.   Researchers noted that the body's response to protein was rapid (within 20 minutes), which suggests taking it close to the beginning of exercise could be beneficial for preventing hypoglycemia. Though more research is needed, there was also evidence showing protein intake could be beneficial for prolonged fasting and preventing overnight lows. -- More info about type 1 and GLP medications. Researchers at ATTD presented the results of a small, seven-month study assessing the effectiveness of semaglutide for people with type 1 diabetes and obesity. During the trial, 36% of participants taking semaglutide spent more than 70% of their time in range, less than 4% of their time below range, and lost more than 5% of their body weight compared to those not taking semaglutide.   Treatment with semaglutide was also associated with reductions in cholesterol and blood pressure. Based on all of these changes, the researchers calculated that the participants who received semaglutide had significantly reduced their risk of heart disease over the next 10 years.   Other studies show that since 2020, prescriptions of GLP-1 medications have grown exponentially for adults with type 1 diabetes between the ages of 18 and 85. https://diatribe.org/diabetes-research/top-diabetes-news-attd-2026   XX Lots of talk about fully closed loops.. CamDiab unveiled theirs.. called Liberty.. which the company says it's the world's first fully closed loop commercial launch. CamDiab offers the FDA-approved mylife CamAPS FX app for automating insulin delivery in MyLife's (formerly Ypsomed Diabetes Care's) insulin delivery pumps. The mylife CamAPS FX on iOS has full compatibility with leading continuous glucose monitors (CGMs). Those include the FreeStyle Libre 3 and Libre 3 Plus from Abbott and the Dexcom G6 so customers can use their preferred device. https://www.drugdeliverybusiness.com/camdiab-unveils-fully-closed-loop-insulin-feature/ XX Insulet reported data on a fully closed-loop automated insulin delivery system in people with Type 2 diabetes. The 24 people in the trial spent 24% more time in the target blood glucose range using the system than when receiving standard injection therapy. Insulet plans to start a pivotal study this year and aims to launch in 2028. Rival insulin pump manufacturer Tandem is on a similar course. Tandem CEO John Sheridan told investors on an earnings call last month that his team plans to start a pivotal trial this year to support a filing with the Food and Drug Administration in 2027. Medtronic disclosed the start of a pivotal trial of its Vivera fully closed-loop algorithm last month, shortly before spinning off the program as part of the MiniMed initial public offering. The algorithm, which is designed to eliminate carb counting and manual food bolusing, achieved a mean time in range of 73.8% without manual user input in a feasibility study.   https://www.medtechdive.com/news/insulet-posts-clinical-data-on-fully-closed-loop-insulin-delivery-system/814516/ XX Congrats to all honored by the 2026 National Scientific and Health Care Achievement Awards from the American Diabetes Association! Shout out to Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES: 2026 Outstanding Educator in Diabetes Award and to  Korey Hood who receives the Richard Rubin award. Dr. Rubin was a pioneer in behavioral science and committed to keeping the person with diabetes at the center of research and care.

In this episode, we explore the world of diabetes and how to effectively manage blood sugar levels with Kathy Levin, RDN, CDCES, DipACLM. As a board-certified lifestyle medicine dietitian with the American College of Lifestyle Medicine and a certified diabetes educator, Kathy has helped countless individuals regain control of their health through simple, sustainable nutrition and lifestyle changes. At the core of Kathy's approach is the signature THRIVE framework — a comprehensive method focused on gradual, realistic habits that lead to lasting results… Hit play to discover: The primary things that raise inflammation in the body and contribute to chronic disease. How Kathy's experience with diabetes has impacted her career path. The ways in which the conventional approach to healthcare can fall short.  Why pediatric diabetes has become more prevalent. Want to find out how to improve blood sugar control, reduce medication, and make sustainable changes that lead to real results? Join the conversation now! Connect with Kathy and her work with Nutritiously Simple here.

In this episode of The Life Possible Podcast, Dr. John Barnes sits down with Franziska Spritzler, RD, CDCES, Medical Science Liaison at Keto-Mojo and a respected voice in the world of low-carb and ketogenic nutrition.Dr. Barnes and Franziska explore why ketones are important as both energy and “signalers” in the human body for appetite suppression and preservation of muscle mass during weight loss as we see during the Ideal Protein protocol! How tools like the Keto Mojo blood glucose and ketone meters, and the Glucose Ketone Index (GKI) can give individuals real insight into what is happening inside their metabolism. They discuss the different ways ketones can be measured, why blood testing is considered the gold standard, and how combining glucose and ketone data can provide a deeper picture of metabolic health.Franziska explains nutritional ketosis, which can support weight loss and improve metabolic health markers, at relatively low ketone levels.  She also discusses deeper ketone levels in therapeutic ketosis, which is often used in research and clinical settings for conditions such as neurological disorders, mental health conditions, and even cancer metabolism.Finally, the episode highlights exciting emerging research on very low-carbohydrate ketogenic diets (VLCKD – like IP Phase 1) and their potential role in a wide range of health outcomes, including weight loss, appetite regulation, binge eating disorder, acne, preservation of lean muscle mass, PCOS and fertility outcomes, and improved metabolic health.

GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTChristine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy Practice and Clinical PharmacistMidwestern University Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations.2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment.Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated.0.1 CEU/1.0 HrUAN: 0107-0000-26-081-H01-PInitial release date: 3/9/2026Expiration date: 3/9/2027Additional CPE details can be found here.

GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight management and ongoing investigations into GLP‑1 therapies for conditions beyond diabetes and obesity. You will gain a timely overview of recent developments in GLP‑1s and how pharmacists can anticipate and support their evolving role in patient care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTChristine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy Practice and Clinical PharmacistMidwestern UniversityGET CE FOR THIS LISTENING!The GameChangers Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that's less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Summarize recent regulatory and clinical updates related to GLP‑1 receptor agonists, including new formulations.2. Describe emerging areas of research into the use of GLP‑1 therapies beyond diabetes and obesity treatment.Rachel Maynard has no relevant financial relationships with ineligible companies to disclose. Christie Schumacher is a speaker for and is on the advisory board for Abbott. All relevant financial relationships have been mitigated.0.1 CEU/1.0 HrUAN: 0107-0000-26-081-H01-PInitial release date: 3/9/2026Expiration date: 3/9/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

What do elite athletes do differently when it comes to fat loss and body composition? In this episode, Vanessa sits down with Emily Mitchell, RD, CSSD, CDCES — former Director of Sports Nutrition at UCLA Athletics, Sports Performance Dietitian for the LA Galaxy, and current Registered Dietitian at Love.Life — to unpack the real nutrition strategies used at the highest levels of sport. You'll learn: The core principles elite athletes use to stay lean while maximizing performance How protein intake supports fat loss and lean muscle retention Why recovery nutrition is a hidden driver of metabolic efficiency How to structure nutrition for sustainable body recomposition The mindset shift from restriction to strategic fueling How to optimize nutrition through fertility, pregnancy, perimenopause, and postmenopause Timeline Mitopure Gummies — The #1 Urolithin A supplement for energy and healthy aging, now in delicious strawberry gummies. Get 20% off at timeline.com/vanessa You'll learn how protein, recovery, and strategic fueling drive fat loss while preserving lean muscle — and how to apply these same principles to fertility, pregnancy, perimenopause, and postmenopause. Protein-Sparing Modified Fasting Library (Coming Soon) Vanessa shares her behind-the-scenes system built from the approach she used to lose 14+ lbs of body fat while preserving lean mass. Join the waitlist: Sign up HERE to be the first to know when it has been released!

Show Notes HOST Melody Hartzler | | Book Appointment AROUND THE TABLE Kara Siedman | ResBiotic In Today's Episode In this episode of the Tables Talk Podcast, Dr. Melody Hartzler sits down with Kara Siedman, RD, CDCES, Director of Partnerships at ResBiotic, to examine how microbiome-driven physiology intersects with hormonal transitions during perimenopause and menopause. As estrogen and progesterone fluctuate and decline, women experience predictable shifts in metabolic regulation, immune signaling, and inflammatory burden. Increasing evidence suggests these changes are tightly linked to alterations in gut microbial diversity, intestinal barrier integrity, and microbial metabolite production. This conversation explores the gut–hormone axis through a mechanistic lens, highlighting how microbiome dysfunction may amplify symptoms such as blood sugar instability, weight gain, estrogen dominance, gastrointestinal distress, and genitourinary changes. Kara draws on clinical experience and emerging research to clarify why many hormonally driven symptoms occur in the absence of overt disease on conventional testing. The episode emphasizes perimenopause as a critical intervention window—one in which targeted dietary, lifestyle, and microbiome-supportive strategies may meaningfully influence long-term cardiometabolic and immune health. Key Takeaways Hormonal decline during perimenopause is closely linked to reduced microbiome diversity and resilience Estrogen loss impacts intestinal barrier function, inflammation, and metabolic regulation The estrobolome plays a central role in estrogen metabolism and symptom expression Microbiome-targeted interventions may reduce cardiometabolic risk during menopause Diet, fiber diversity, and precision biotics are foundational tools for supporting this transition Episode Highlights Hormonal Transitions & the Gut–Hormone Axis Estrogen and progesterone fluctuations in perimenopause Bidirectional signaling between endocrine function and the microbiome Declining microbial diversity and reduced short-chain fatty acid production Inflammation, Metabolism, and Insulin Resistance Metabolic endotoxemia and LPS-driven inflammation Microbiome contributions to blood sugar dysregulation and weight gain Links between dysbiosis, immune activation, and chronic disease risk The Estrobolome & Estrogen Metabolism Beta-glucuronidase activity and estrogen deconjugation Microbial reactivation of estrogen and clinical implications Estrogen dominance, elimination pathways, and gut health Vaginal Microbiome & Genitourinary Health Estrogen-dependent Lactobacillus depletion Increased risk of UTIs and yeast infections Gut–vaginal microbiome crosstalk and clinical considerations Clinical Interventions to Support Microbiome Resilience Mediterranean-style dietary patterns and plant diversity Fiber intake, resistant starch, prebiotics, probiotics, and postbiotics Stress, sleep disruption, medications, and microbiome vulnerability Precision supplementation during the menopausal transition

Fueling your body with intention Guest Bio: Marcus Harris, RDN, CDCES, is an experienced Registered Dietitian and Diabetes Educator with a 15-year background of working with clients to help them achieve their health and wellness goals!

On this episode of danatech Talks, a special series from The Huddle: Conversations with the Diabetes Care Team, Dana Moreau is joined by Amy Hess-Fischl, MS, RD, LDN, CDCES, to explore the real-world challenges of prescribing diabetes technology. Amy shares practical strategies for navigating coverage pathways, documentation requirements, denials, and affordability, while offering workflow tips to help providers streamline access for their patients. This episode was supported by educational grant funding from Abbott. Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare Professionals Listen to the first episode of our danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionals Listen to more episodes of The Huddle at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Huddle Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fueling your body with intention On this episode of Real Wellness, Dr. Crystal explores what “good nutrition” actually means—beyond trends and quick fixes—and what it looks like in real life for an active individual. She's joined by Marcus Harris, a registered dietitian and diabetes educator, who works hands-on with clients every day to help them build lean muscle, lose weight, and meet their nutritional needs—especially those navigating appetite changes while on weight loss medications. #LELEARN #EDULFsocial Guest Bio: Marcus Harris, RDN, CDCES, is an experienced Registered Dietitian and Diabetes Educator with a 15-year background of working with clients to help them achieve their health and wellness goals!

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast. The Points of CARE, the official podcast of Diabetes, Obesity, and Cardiometabolic CARE, will highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. In this special inaugural episode, host Richard Beaser, MD also discusses the ADA's Obesity Association and the "Standards of Care in Overweight and Obesity." 4:15 Beaser speaks with Alissa Segal, PharmD, RPh, CDCES, CDTC, FCCP. Dr. Segal is editor in chief of Diabetes, Obesity, and Cardiometabolic CARE and professor of pharmacy practice at the Massachusetts College of Pharmacy and Health Sciences. Her editorial, "Diabetes, Obesity, and Cardiometabolic CARE: Building New From a Strong Foundation," is available for free at doi.org/10.2337/doci25-0010. 13:00 Samar Hafida, MBCCh, joins the conversation. Dr. Hafida is a board-certified endocrinologist and weight management specialist at Boston Medical Center and assistant professor of medicine (Endocrinology, Diabetes, Nutrition & Weight Management) at the Boston University Chobanian & Avedisian School of Medicine. She is also vice president of the ADA's Obesity Association. Her editorial, "Introducing the Obesity Association and the Launch of Our Official Journal," is available for free at doi.org/10.2337/doci25-0012. 17:55 Dr. Hafida discusses "Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity." This article is available for free at doi.org/10.2337/doci25-0008. 20:05 Richard and Alissa highlight a few articles from the first issue of Diabetes, Obesity, and Cardiometabolic CARE. Simpkins et al. "Association of Type 2 Diabetes Subgroups With Incident Peripheral Neuropathy" doi.org/10.2337/doc25-0051 Livingston et al. "The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program" doi.org/10.2337/doci25-0005. Davidson et al. "Effectiveness of Using Patient-Defined Meal Sizes to Determine Bolus Doses of Insulin" doi.org/10.2337/doc25-0018 Ali et al. "Patterns of Prescription Discontinuation, Reinitiation, and Switching of Subcutaneous Semaglutide and Tirzepatide in Adults With Obesity" doi.org/10.2337/doc25-0026 Masiano et al. "Type 2 Diabetes Treatment and Experience With Hospitalization in Older Adults: A Convergent Mixed-Methods Study" doi.org/10.2337/doc25-0009 Young et al. "The Critical Role of Diabetology Pharmacists in Improving Cardiovascular-Kidney-Metabolic Care and Outcome" doi.org/10.2337/doc25-0049 To learn more about Diabetes, Obesity, and Cardiometabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode of The Healthy Diabetic Podcast, I sit down with Rachel Faber MS, RD, LDN, CDCES and Nicole Cordoba RN, CDCES, known online as CDE Diabuddies, to explore what diabetes care looks like when providers are also patients—and why pediatric diabetes care often feels worlds apart from adult care.Rachel and Nicole share their personal diagnosis stories—one diagnosed at age 4, the other at 17—and how those experiences shaped their paths into healthcare as Certified Diabetes Care and Education Specialists (CDCES). Together, they walk through what pediatric diabetes education which actually includes: multi-day hospital education, family involvement, hands-on insulin training, mental health screening, and structured follow-ups.The conversation dives deep into the systemic gaps that appear when patients transition into adult care, including shorter visits, less education, fewer resources, and limited emotional support. Ken and the guests discuss misdiagnosis, insurance barriers, Dexcom-induced anxiety, parental dynamics, and why flexibility—not rigidity—is key to long-term diabetes success.

In this episode of the Food Dignity Podcast, Clancy is joined by Denee Bex, a Registered Dietitian and CDCES from the Diné (Navajo) Nation and the founder of Tumbleweed Nutrition LLC. Together, they explore how food sovereignty, representation, and lived experience shape nutrition work in Native communities and why listening, humility, and cultural respect must be at the center of food and health conversations.

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let's talk about what's changed and how to better care for our older adults living with diabetes. 2026 Standards of Care in Diabetes:  https://diabetesjournals.org/care/issue/49/Supplement_1 Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES:  https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/  

When your food allergy becomes the reason you have to walk out of your own professional presentation, something is deeply broken. That's exactly what happened to Christina LiPuma, MPH, RDN, CDCES, when she had a severe allergic reaction at a national nutrition conference. The culprit? A mislabeled "curry bowl" and a series of "I don't think so" answers that should never have been good enough. You ask if a dish contains peanuts. "I don't think so," says one staffer. "Pretty sure it doesn't," says another. Minutes later, your throat tingles, your heart races—and you realize what "pretty sure" can cost. This week on Eating at a Meeting Podcast LIVE, I'm talking with Christina—Registered Dietitian, Certified Diabetes Care & Education Specialist, and former Policy Associate at the Center for Science in the Public Interest—about what happens when event dining fails, and how we can make it right. We'll discuss:

In this episode of The Huddle: Conversations with the Diabetes Care Team, Jami Klein RN, CDCES, Senior Manager of Clinical Education at Dexcom, joins Davida Kruger, MSN, APN-BC, BC-ADM, Certified Nurse Practitioner at Henry Ford Health System, for a practical conversation on integrating continuous glucose monitoring into primary care. Together, they explore Dexcom's CGM clinic workflow toolkit, highlighting how nurse practitioners and DCESs can streamline implementation, improve efficiency, and empower patients through data-driven care. This episode was supported by Dexcom. You can view Dexcom's CGM workflow by visiting dexcom.com/clinical-workflow. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast. Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Liz Unruh is joined by Kelly Eagan, PharmD, BCPS, BCACP, CDCES, the lead clinical pharmacist at Riverside's Cardiology Pharmacotherapy Clinic (CPC). Discover how clinical pharmacists play a crucial role in patient care management, help manage chronic conditions, and optimize medication therapy to ensure best outcomes for patients. Tune in to understand the unique value they bring to the healthcare team!

On this episode of Danatech Talks–a special series from The Huddle– Paola Acevedo, PharmD, CDCES, walks through how to simplify the process of prescribing diabetes technology. Paola discusses common pain points both clients and prescribers may face related to documentation, coverage and affordability, and accessibility. She also shares practical strategies, systems and workflows providers and practices can implement to help navigate through these potential challenges.This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsExplore danatech's technology affordability tool: Diabetes Technology Affordability OptionsListen to previous episodes of our Danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionalshttps://thehuddle.simplecast.com/episodes/understanding-cgms-and-interpreting-data-for-beginners  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode 95 of Astonishing Healthcare features six previous guests on the show who share astonishing observations from 2025 and some bold predictions for the New Year! Industry veteran Jeffrey Hogan, our General Counsel and Chief Compliance Officer, Lloyd Fiorini, ERISA law expert Nick Welle, two of our clinical leaders – Sarra Izadi, PharmD, Chief Clinical Officer, and Bonnie Hui-Callahan, PharmD, CDCES, Sr. Director, Clinical Programs, and our Chief Technology Officer and Co-Founder, Ryan Kelly, joined us for this round-robin discussion that's packed with insightful reflections and optimism about the future. We won't ruin it in the show notes, but based on what we saw in 2025: Everyone has finally had enough of the costs and opacity of the U.S. healthcare system – a $70k family premium is truly astonishing It's surprising that, despite the lawsuits, warnings, and reform efforts, the proverbial hammer didn't drop on anyone for not being a good health plan fiduciary The speed and impact of AI have broadly been more positive than expected The rise of cardio-diabesity How GLP-1s helped shift the balance of power in the pharmaceutical supply chain And in 2026, we may see: Employers fight back – they take agency over their plans, and for first movers that started with transitioning to aligned PBMs, it's “game on” for the rest of their health plans The cash price – or acquisition cost – of drugs in the U.S. becomes the baseline – i.e., we finally see a real change in how drugs are priced ICHRAs and other alternative models become more popular Employers look to new clinical programs and models that demonstrate a return on their spending AI become more important for clinical workflows (not decision-making, at least not yet) Pharmaceutical manufacturers find themselves with increasing bargaining power vs. traditional PBMs A new Stanley Cup champion, and a Super Bowl ring for… Related Content Judi Health Policy Pulse: 2025 Regulatory Roundup, the Push for PBM Reform Replay - Unifying Medical and Pharmacy Benefits: The Blueprint for Better Employee Health and Wellness AH094 - How Unified Claims Processing Evolved from Pharmacy: Improving Member Care & Operating Efficiency Health Benefits 101: The Importance of Clinical Programs How to obtain Rx data and what to do with it For more information about Capital Rx and this episode, please visit Judi Health - Insights.

In this episode, we sit down with Sarah Hormachea, MS, RD, CDCES, BC-ADM, a Diabetes Care and Education Specialist whose work spans national guideline committees, tribal community health, and clinical practice. Sarah breaks down how medical nutrition therapy (MNT) for type 1 diabetes has transformed—moving away from rigid, prescriptive diet rules and toward individualized, culturally inclusive care.She shares what's changed in the latest nutrition guidelines, how technology and real-time glucose insights are reshaping patient conversations, and what the first year after diagnosis really looks like for many people. Sarah also dives into emerging research, from plant-forward approaches to ketogenic patterns, gut health, and medication advances that could influence nutrition strategies in the years ahead.Listeners will also learn where to find reliable resources, how to stay connected with the latest developments, and how to access Sarah's work and insights.Sarah Hormachea is a Diabetes Care and Education Specialist who believes nutrition therapy should honor both culture and science. Drawing on 10+ years in clinical and community settings, she helps make diabetes care more personal, inclusive, and effective.“Sometimes it takes these diagnoses for people to stop and reflect and recognize that health is wealth, right? And if you have, if you don't have your health - what do you have?”Question of the Day:How has nutrition played a role in how you (or a loved one) manages or navigates type 1 diabetes? On This Episode You Will Learn:How Diabetes Care and Education Specialists (DCES) support people with type 1 diabetes at every stage of care.The most important updates from recent medical nutrition therapy guidelines—and why they matter.What early nutrition support looks like immediately after diagnosis and during the first year.Common nutrition myths in type 1 diabetes and how to approach them with evidence and compassion.The research and trends poised to shape the future of type 1 diabetes nutrition care.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Sarah Hormachea!Website URL: www.sarahhormachea.com Instagram URL: https://www.instagram.com/sarah.hormachea/ Facebook URL: https://www.facebook.com/sarahhormachea.diabetescare LinkedIn URL: https://www.linkedin.com/in/sarahhormachea/ 

Send us a textEven though Diabetes Awareness Month wrapped up in November, staying aware of what's happening inside our bodies is a year-round priority. And that's exactly why this conversation is a must-listen!I had the incredible honor of interviewing Jessica Jones, MS, RD, CDCES, a nationally recognized dietitian, diabetes expert, and co-founder of Diabetes Digital, a telehealth platform that delivers culturally inclusive nutrition counseling, covered by insurance. She brings clarity, warmth, and evidence-based truth to a topic that so many people fear—prediabetes and diabetes.This episode is packed with practical gems, approachable science, and reassurance that change doesn't require restriction, guilt, or overwhelm.This is an episode you'll want to share with friends, family, and anyone who's navigating prediabetes or diabetes.➖Connect with Jessica Jones, https://linktr.ee/diabetesdigitalco

In this episode I chat with team dietitian Erika Behrmann RD, CDCES, CSSD, LDN about how to navigate being a runner with body composition goals.Need support with this? Work with Erika 1:1 here: https://holleyfuelednutrition.com/nutrition-coachingPod episode on establishing normal eating patterns: https://open.spotify.com/episode/06NKTGdpjH8rnqfx4p4clb?si=zMtOQwPhRViHtKBtn1vqTAPod episode on GLP-1 Medications: https://open.spotify.com/episode/28GZOPH9dhEdp5a79la2LE?si=YBIGaYm3TReJMjqS-Lq7EQPod episode on Bariatric Surgery: https://open.spotify.com/episode/6FEHuZTZGUMrYhhHudKgEG?si=qD_A0WKzQDmOduWhlIK5LgThank you BetterHelp for sponsoring this episode! To save 10% on your first month of therapy, visit: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.betterhelp.com/holleyfueled⁠⁠⁠⁠⁠For entrepreneurs: ⁠⁠⁠Subscribe to the Holley Fueled Business Podcast ⁠https://creators.spotify.com/pod/profile/holleyfuelednutrition/subscribe

Send us a textLisa La Nasa is a returning guest on our show! Be sure to check out her first appearance on episode on 704 of BBR!Lisa La Nasa is a mom of two, wife, adventurer, coffee fanatic, and founder and CEO of diaVerge Diabetes. Lisa founded diaVerge Diabetes in 2015 after her own personal discovery of the empowerment and complete lifestyle transformation that can come from gaining better control of type 1 diabetes.She has successfully been maintaining A1c levels

Kristine Batty, PHD, APRN, BC-ADM, CDCES, FADCES joins this episode of Danatech Talks–a special series from The Huddle– to provide a high-level overview on continuous glucose monitors (CGMs). Kristine touches on the basics of how CGMs work, what CGM devices are out there today, what the different devices measure, and how CGM technology impacts clinical decision making. This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsListen to the first episode of our Danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionals Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Madalyn and I talk all things CARBS!! She shares about the purpose that carbs serve, how not all carbs are created equal and how you can use them to balance a meal. We also talk about the stigma around body size and diabetes. Also did I mention she is a runner! This episode originally aired June 12, 2023. Follow Madalyn on Instagram @diabetes.rd. You can also check out her website http://madalyndiabetesnutrition.com/. Have questions? DM me on Instagram @runnergirldietitian

Chelsea Hayman, PA-C, CDCES, is a Physician Assistant and Certified Diabetes Care & Education Specialist with nearly a decade in endocrinology. She is the founder of Empowered Glucose, where she helps women with diabetes and insulin resistance feel confident, informed, and in control of their health. Chelsea combines clinical expertise with a supportive, real-life approach, focusing on mindset, sustainable habits, and simplifying diabetes care. As a mom of two, she's passionate about helping women create balance and lasting change without striving for perfection. Chelsea's Website: www.empoweredglucose.com

A very common fear among adults with type 1 is having a child diagnosed with T1D. My guest this week was diagnosed at age 7 and he says he held his breath each time one of his three children passed the milestone. But then, his youngest was diagnosed at age 8. I'm talking to Brian Foster about that experience, what surprised him, how everyone's doing now and a lot more. He's also a CDCES and has a master's degree in exercise physiology. Brian is an Ironman triathlete who has completed more than 50 marathons and we get his advice about the endurance sports he loves. Brian's blog My Sweet Hat Trick here Our previous episodes with marathon runners with T1D here Previous episodes with endurance athletes with T1D here This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

In this episode I chat with my colleague Ben Tzeel, RD, CDCES, CSCS about his own journey navigating learning how to fuel for sports with type 1 diabetes along with his top evidence based approaches for helping fellow athletes who have type 1 diabetes.Ben is a registered dietitian, strength coach, and T1D vet of over 20 years who specializes in providing you with the blueprint to amazing blood sugars so you can eat the foods you love, do the things you love, and live life on YOUR terms, NOT diabetes' terms. Over the years, Ben has had the pleasure of using his professional and personal experiences to help thousands of people with diabetes to improve their A1cs, transform their bodies, and feel FREE again. Thank you BetterHelp for sponsoring this episode! To save 10% on your first month of therapy, visit: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.betterhelp.com/holleyfueled⁠⁠⁠⁠⁠To work with us in our 1:1 nutrition coaching program or book a consult: ⁠⁠⁠⁠⁠https://holleyfuelednutrition.com/nutrition-coaching⁠⁠⁠For entrepreneurs: ⁠⁠⁠Subscribe to the Holley Fueled Business Podcast Follow Ben on IG: @manoftzeel